Title: Is UGT1A1*28 homozygosity the strongest predictor for severe hematotoxicity in patients treated with 5-fluorouracil (5-FU)-irinotecan (IRI)? Results of the PETACC 3-EORTC 40993-SAKK 60/00 trial comparing IRI/5-FU/folinic acid (FA) to 5-FU/FA in stage II-III colon cancer (COC) patients
Authors: Roth, A. D
Yan, P
Dietrich, D
Fiocca, R
Bodoky, G
Labianca, R
Cunningham, D
Van Cutsem, Eric
Bosman, F
Tejpar, Sabine #
Issue Date: 2008
Publisher: Grune & Stratton
Host Document: Journal of Clinical Oncology vol:26 issue:15 pages:4036-4036
Conference: -
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Molecular Digestive Oncology (+)
Clinical Digestive Oncology (+)
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.